These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 9636465)

  • 21. Acute cardiac ongoing rejection: comparison between different strategies.
    Forni A; Faggian G; Luciani GB; Lamascese N; Mazzucco A
    Transplant Proc; 2001 May; 33(3):2395-7. PubMed ID: 11377573
    [No Abstract]   [Full Text] [Related]  

  • 22. Implication of HLA mismatch in the clinical outcome of orthotopic heart transplantation.
    Aziz TM; Sheldon S; el-Gamel A; Krysiak P; Campbell C; Rahman A; Dyer P; Yonan N; Deiraniya A
    Transplant Proc; 1998 Aug; 30(5):1917-9. PubMed ID: 9723332
    [No Abstract]   [Full Text] [Related]  

  • 23. Early cyclosporine blood levels impact the incidence of acute rejection and overall mortality in the first year after heart transplantation.
    Gómez-Sánchez MA; Delgado JF; Escribano P; Santos M; Sotelo T; Gil R; Hernández-Afonso J; Ortuño B; Romero F; Sáenz de la Calzada C; Rodriguez JE; Rufilanchas JJ
    Transplant Proc; 1998 Aug; 30(5):1671-2. PubMed ID: 9723237
    [No Abstract]   [Full Text] [Related]  

  • 24. FK 506 rescue therapy for irreversible airway rejection in heart-lung transplant recipients: report on five cases.
    Knoop C; Antoine M; Vachiéry JL; Yernault JC; Estenne M
    Transplant Proc; 1994 Dec; 26(6):3240-1. PubMed ID: 7527957
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term nephrotoxicity of low doses of cyclosporine in heart transplant recipients.
    Ben Hmida M; Baumelou A; Desruesnnes M; Cabrol A; Pavie A; Grandjbakhch I; Cabrol C
    Transplant Proc; 1995 Oct; 27(5):2725-7. PubMed ID: 7482891
    [No Abstract]   [Full Text] [Related]  

  • 26. Medium-term outcome of tacrolimus immunosuppression following rejection or graft dysfunction in heart transplant patients.
    Marcus N; Khaghani A; Burke M; Yacoub M; Banner N
    Transplant Proc; 1998 Jun; 30(4):1134-5. PubMed ID: 9636460
    [No Abstract]   [Full Text] [Related]  

  • 27. Modern application for an old compound: 8-methoxypsoralen for photochemotherapy after heart transplantation.
    Meiser BM; Kur F; Uberfuhr P; Reichenspurner H; Kreuzer E; Reichart B
    Transplant Proc; 1993 Dec; 25(6):3307-8. PubMed ID: 8266554
    [No Abstract]   [Full Text] [Related]  

  • 28. Histopathological findings in heart transplant patients under tacrolimus-mycophenolate mofetil versus cyclosporine microemulsion-azathioprine.
    Sgrosso JL; Ferrer J; Araujo G; Romeo L; Parisi C; Vázquez MC
    Transplant Proc; 2002 Feb; 34(1):115-6. PubMed ID: 11959214
    [No Abstract]   [Full Text] [Related]  

  • 29. Induction therapy with cyclosporine without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients.
    Jazzar A; Fagiuoli S; Sisson S; Zuhdi N; Cooper DK
    Clin Transplant; 1995 Aug; 9(4):334-9. PubMed ID: 7579743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic approach with patient-specific cyclosporine administration protocol in renal transplantation.
    Sernyak PS; Chernobrivtsev PA; Kalinin DI; Lunyova AG; Denisov VK
    Transplant Proc; 1997; 29(1-2):296. PubMed ID: 9123003
    [No Abstract]   [Full Text] [Related]  

  • 31. Mycophenolate mofetil with lower cyclosporine dose in high-risk renal transplant recipients.
    Esmeraldo RM; Donadi MO; Oliveira ML; Ponte CN; Pinheiro PM
    Transplant Proc; 1999 Nov; 31(7):3007-8. PubMed ID: 10578367
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunosuppression switch in pediatric heart transplant recipients: cyclosporine to FK 506.
    Swenson JM; Fricker FJ; Armitage JM
    J Am Coll Cardiol; 1995 Apr; 25(5):1183-8. PubMed ID: 7534779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of humoral rejection in heart transplant recipients treated with tacrolimus or cyclosporine A.
    Behr TM; Richter K; Fischer P; Spes CH; Meiser B; Reichart B; Pongratz D; Feucht H; Theisen K; Angermann CE
    Transplant Proc; 1998 Aug; 30(5):1920-1. PubMed ID: 9723333
    [No Abstract]   [Full Text] [Related]  

  • 34. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary rejection diagnosis after lung and heart-lung transplantation.
    Reichenspurner H; Dienemann H; Rihl M; Wagner F; Meiser BM; Kur F; Hammer C; Forst H; Kreuzer E; Reichart B
    Transplant Proc; 1993 Dec; 25(6):3299-300. PubMed ID: 8266550
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term safety and efficacy of Neoral in heart transplantation.
    Yonan NA; Aziz T; el-Gamel A; Campbell CS; Rahman AN; Deiraniya AK
    Transplant Proc; 1998 Aug; 30(5):1906-9. PubMed ID: 9723328
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunosuppression induction with rabbit antithymocyte globulin in heart transplantation patients: 6-year experience at the Sheba Medical Center.
    Lavee J; Bar-Zohar D; Har-Zahav Y; Freimark D; Casif Y; Shinfeld A; Smolinsky AK
    Transplant Proc; 2000 Jun; 32(4):737-9. PubMed ID: 10856565
    [No Abstract]   [Full Text] [Related]  

  • 38. A prospective study comparing safety and efficacy of mycophenolate mofetil versus azathioprine in primary liver transplant recipients.
    Fischer L; Sterneck M; Gahlemann CG; Malago M; Rogiers X; Broelsch CE
    Transplant Proc; 2000 Nov; 32(7):2125-7. PubMed ID: 11120098
    [No Abstract]   [Full Text] [Related]  

  • 39. Neoral conversion study: shift from Sandimmune classic formulation to Sandimmune Neoral in heart and lung transplant patients.
    Svendsen U; Larsen K; Allermand H; Thayssen P; Jensen S; Pettersson G
    Transplant Proc; 1995 Dec; 27(6):3477. PubMed ID: 8540057
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of rejection on late graft function after heart transplantation.
    Livi U; Milano A; Caforio AL; Grassi G; Feltrin G; Boffa GM; D'Agnolo A; Angelini A; Thiene G; Casarotto D
    Transplant Proc; 1994 Oct; 26(5):2727-8. PubMed ID: 7940855
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.